Clinical Trials Logo
  1. Home
  2. Chronic Obstructive Pulmonary Disease
  3. NCT05029349

Exploration of the VOLATOLOM in the Stable Severe COPD (Chronic Obstructive Pulmonary Disease) — VOC-BPCO  

Chronic Obstructive Pulmonary Disease Severe Clinical Trial

Official title:
Exploration of the VOLATOLOM in the Stable Severe COPD (Chronic Obstructive Pulmonary Disease)

Clinical Trial Summary

This is a prospective interventional study to determine whether the profile of volatile organic compounds (VOCs) present in exhaled air (VOLATOLOM) is reproducible in stable severe COPD (Chronic Obstructive Pulmonary Disease) patients.

Clinical Trial Description

After being informed about the study, all patients giving written informed consent and meeting the eligibility criteria will undergo 4 visits spaced 4 to 6 weeks apart. The first visit V1 will be about 45 minutes duration. The others ones (V2 to V4) will be about 30 minutes duration. All sessions will be carried out in the Pneumology Department of the Foch Hospital, volatolomics platform (Exhalomics®). Exhalation collection will be performed at each visit in order to perform the volatolom analysis. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT05029349
Study type Interventional
Source Hopital Foch
Contact Philippe Devillier, MD PhD
Phone 0146252791
Email p.devillier@hopital-foch.com
Status Recruiting
Phase N/A
Start date October 13, 2021
Completion date June 13, 2023
View Details
See also
  Status Clinical Trial Phase
Active, not recruiting NCT03923660 - Ventilatory Adaptation to Concentric Versus Eccentric Exercise in Patients With Severe COPD N/A
Recruiting NCT06008210 - A Decision Aid on End-of-life Care for Patients With Advanced COPD and Their Family N/A
Not yet recruiting NCT05539547 - Effect of NMES on Quadriceps Muscle Strength and Endurance in Patients With COPD Early Phase 1
Recruiting NCT04018729 - Cell Therapy Associated With Endobronchial Valve Phase 2/Phase 3
Suspended NCT04848012 - Efficacy of an Advanced Auto-titrating NIV in COPD N/A
Recruiting NCT06198309 - Risk Prediction Model for Exacerbating Phenotype in Patients With Chronic Obstructive Pulmonary Disease
Recruiting NCT03398772 - Effects of a Comprehensive Health Coaching Program in Advanced Chronic Obstructive Pulmonary Disease. N/A
Recruiting NCT06247397 - Effect of HIgh-flow Therapy in Long-term Oxygen Therapy N/A
Completed NCT05259280 - Observational Study of the Wellinks Solution Impact on Quality of Life and Clinical Outcomes in Patients With COPD N/A
Not yet recruiting NCT06212765 - Oral Citrulline Supplementation in COPD Patients With Malnutrition Phase 3
Completed NCT02962999 - Effect Of Ketamine Infusion In Patients With COPD Applied One Lung Ventilation Phase 4
Not yet recruiting NCT06229509 - Study of the Cytokine Response During Exercise Dyspnea in Patients With Chronic Obstructive Pulmonary Disease (COPD). Effect of Body Composition N/A
Completed NCT05431218 - Association of Cathelicidin and Vitamin D Levels With the Category and Course of COPD Phase 4
Recruiting NCT04069312 - Roflumilast or Azithromycin to Prevent COPD Exacerbations (RELIANCE) Phase 4
Recruiting NCT05575336 - Assessment of the Effectiveness, Socio-economic Impact and Implementation of a Digital Solution for Severe Patients N/A
Completed NCT02998515 - Effects of Different Oxygen Devices in Hypoxemic COPD Patients N/A
Completed NCT04533516 - Additional Manual Therapy Over Inspiratory Muscle Training in COPD N/A
Recruiting NCT06072690 - Respiratory and Cardiovascular Alterations in Patients With Chronic Obstructive Pulmonary Disease